Fig. 5From: Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patientsComparison of Exo-PD-L1 and sPDL1 levels between PD-L1 IHC staining positivity and negativity. a, b Exo-PD-L1 (a) and sPDL1 (b) levels in the PD-L1 IHC positive group (n = 23) and negative group (n = 62) of NSCLC patientsBack to article page